STAMPOUT: Study of Antibody for Methamphetamine Outpatient Therapy.
Phase of Trial: Phase I/II
Latest Information Update: 23 May 2018
At a glance
- Drugs IXT-m200 (Primary)
- Indications Drug abuse
- Focus Pharmacokinetics; Proof of concept
- Acronyms STAMPOUT
- Sponsors InterveXion Therapeutics
- 23 May 2018 According to an InterveXion Therapeutics media release, the details of the study design will be presented at the 2018 College on Problems of Drug Dependence.
- 10 May 2018 According to an InterveXion media release, the first patient has been enrolled in this trial.
- 24 Apr 2018 Planned primary completion date changed from 1 Jun 2019 to 1 Nov 2019.